Navigation Links
Flightless mosquitoes developed to help control dengue fever
Date:2/22/2010

Irvine, Calif. A new strain of mosquitoes in which females cannot fly may help curb the transmission of dengue fever, according to UC Irvine and British scientists.

Dengue fever causes severe flulike symptoms and is among the world's most pressing public health issues. There are 50 million to 100 million cases per year, and nearly 40 percent of the global population is at risk. The dengue virus is spread through the bite of infected female Aedes aegypti mosquitoes, and there is no vaccine or treatment.

UCI researchers and colleagues from Oxitec Ltd. and the University of Oxford created the new breed. Flightless females are expected to die quickly in the wild, curtailing the number of mosquitoes and reducing or even eliminating dengue transmission. Males of the strain can fly but do not bite or convey disease.

When genetically altered male mosquitoes mate with wild females and pass on their genes, females of the next generation are unable to fly. Scientists estimate that if released, the new breed could sustainably suppress the native mosquito population in six to nine months. The approach offers a safe, efficient alternative to harmful insecticides.

Study results appear in the early online edition of the Proceedings of the National Academy of Sciences for the week of Feb. 22. The research is receiving funding support from the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative, which was launched to support breakthrough advances for health challenges in the developing world.

"Current dengue control methods are not sufficiently effective, and new ones are urgently needed," said Anthony James, Distinguished Professor of microbiology & molecular genetics and molecular biology & biochemistry at UCI and an internationally recognized vector biologist. "Controlling the mosquito that transmits this virus could significantly reduce human morbidity and mortality."

Using concepts developed by Oxitec's Luke Alphey, the study's senior author, researchers made a genetic alteration in the mosquitoes that disrupts wing muscle development in female offspring, rendering them incapable of flight. Males' ability to fly is unaffected, and they show no ill effects from carrying the gene.

"The technology is completely species-specific, as the released males will mate only with females of the same species," Alphey said. "It's far more targeted and environmentally friendly than approaches dependent upon the use of chemical spray insecticides, which leave toxic residue."

"Another attractive feature of this method is that it's egalitarian: All people in the treated areas are equally protected, regardless of their wealth, power or education," he added.

James and Alphey have pioneered the creation of genetically altered mosquitoes to limit transmission of vector-borne illnesses. While their current work is focused on the dengue fever vector, they noted that this approach could be adapted to other mosquito species that spread such diseases as malaria and West Nile fever.


'/>"/>

Contact: Tom Vasich
tmvasich@uci.edu
949-824-6455
University of California - Irvine
Source:Eurekalert

Related medicine news :

1. Smaller mosquitoes are more likey to be infected with viruses causing human diseases
2. Vaccine and drug research aimed at ticks and mosquitoes to prevent disease transmission
3. Fleas and Ticks and Mosquitoes! Oh My!
4. Mega-Catch™ 3000 Combination Lure Attracts Asian Tiger Mosquitoes (Aedes Albopictus)
5. Private Sector, President's Malaria Initiative Join Forces to Strengthen Angolas Capacity to Control Mosquitoes
6. Microbiotic technology developed for microinjection of zebrafish embryos
7. Lab-on-chip testing for bird flu developed by Singapore scientists
8. Mobility-enhancing device developed at University of Alberta will receive prestigious da Vinci Award
9. New Denver Area Program Developed For Teens in Crisis
10. Genomic technologies to identify toxic chemicals should be developed
11. New system for classifying infant lung disease developed
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... Columbus OH. ... selected as one of few medical professionals in the country to sit on the ... of Juvly Aesthetics, in just 2 years Dr. Harper helped propel the clinic from ...
(Date:3/28/2017)... ... March 28, 2017 , ... Prominant ... Surgical, Inc. is thrilled to offer the recently FDA-approved Obalon Balloon System to ... adds to SkyLex Advanced Surgical’s already comprehensive list of weight-loss services. Dr. ...
(Date:3/28/2017)... ... , ... With expansion and efficiency in mind, Patten Seed Company completed relocation ... plant opened in Marshallville in 2006, and a bagging and shipping facility has been ... of Patten Seed operations to the Middle Georgia location from their previous home in ...
(Date:3/28/2017)... ... ... Thank you to all who attended Capio Partners Winter 2017 Healthcare Leadership Symposium in ... and offered an opportunity to collaborate and network with healthcare colleagues across the United ... gathered for a lively discussion on trends and issues that healthcare leaders will face ...
(Date:3/28/2017)... ... ... Bacteria and fungi are probably not the first ingredients that come to mind when thinking ... in your diet can actually improve health outcomes. And the good news is they may ... a new peer-reviewed paper led by Maria Marco, Ph.D. , University of ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... England , March 28, 2017 ... collaborative research with Cambridge ... Therapeutics Consortium   The Milner Therapeutics Institute today ... Consortium. Elysium Health has committed significant investment for collaborative projects ... the next four years. This is the first major research ...
(Date:3/27/2017)... , March 27, 2017 ... better understand Eli Lilly and its partnering interests and activities ... 2010 report provides an in-depth insight into the partnering activity ... On demand company reports are prepared upon purchase to ... company data. The report will be delivered in ...
(Date:3/27/2017)... -- ImMAGE Biotherapeutics (OTCMKTS: IMMG), an early-stage biotechnology company, announced ... efficacy studies. The company is harnessing the power of ... A, in an effort to find a better treatment ... 4 weeks of treatment in transgenic mice, the lead ... a full toxicology report of various organs. Cytotoxic T-cells ...
Breaking Medicine Technology: